Citadel Advisors
AMIX

Citadel Advisors’s Autonomix Medical AMIX Stock Holding History

Citadel Advisors’s Portfolio AMIX Stock Details AMIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-558
Closed -$20.5K – 15467
2025
Q1 		$20.5K Sell
558
-1,722
-76% -$95.2K ﹤0.01% 13125
2024
Q4 		$180K Buy
+2,280
New +$403K ﹤0.01% 10618

Other funds holding AMIX

Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Citadel Advisors's AMIX Position: Q2 2025 in Review

Citadel Advisors sold out of Autonomix Medical (AMIX) in Q2 2025, closing a stake of 558 shares — an estimated $20.5K sold.

Citadel Advisors first reported a position in AMIX in Q4 2024 and held it in 2 quarters. The position peaked at $180K in Q4 2024. 14 funds tracked by Wall St. Rank hold AMIX as of Q2 2025.

  • Citadel Advisors reported no remaining Autonomix Medical position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 558 Autonomix Medical shares in Q2 2025, an estimated $20.5K.
  • Citadel Advisors first reported a position in Autonomix Medical in Q4 2024 and held it in 2 quarters.
  • Citadel Advisors's Autonomix Medical position peaked at $180K in Q4 2024.
  • 14 funds tracked by Wall St. Rank held Autonomix Medical as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.